ICICI Lombard Q1 FY25: Strong growth justifies premium valuation
Highlights Premium growth much above the industry growth Growth in motor insurance accelerated, strong growth in group health business Combined
Read MoreHighlights Premium growth much above the industry growth Growth in motor insurance accelerated, strong growth in group health business Combined
Read MoreThe Budget will have to address demand-side challenges while making provisions to simplify regulations. Highlights Private capex will require an
Read MoreWhile there is still room for margin expansion for the legacy business, the stock is now more a play on
Read MoreStrong balance sheet, monopolistic business, and other factors augur well for the company. Highlights Expanding production capacity to support growth
Read MoreThe company expects to gradually recoup margin as revenue momentum picks up. Highlights Better-than-expected performance on top line, ERD suppressed
Read MoreThe return of demand and waning pricing pressure are among several positive factors. Highlights Strong execution riding on BSNL order
Read MoreUS retail inflation is likely to cool down faster than expected as labour market is back in balance and excess
Read MoreThe company has a solid balance sheet and the earnings outlook is robust. Highlights Revenues rose 4 percent in Q1
Read MoreUnlike most SFBs, Capital’s loan book is largely secured and the liability profile is granular. Highlights Tepid debut in February,
Read MoreOperating profit likely to be ahead of revenue growth. Key highlights Gradual sequential improvement in domestic businesses International businesses remain
Read More